CRT 2026

Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

Moderator(s)

• 

  Justin E. Davies, MD, PhD

  Cardiologist
  Imperial College London
  London, England, United Kingdom

  Disclosure information not submitted.
• DL

  David P. Lee, MD

  Professor of Medicine
  Stanford University
  Stanford, California, United States

  Disclosure information not submitted.
• 

  Timir Paul, MD, PhD, FACC, FSCAI

  Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
  University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
  Brentwood, Tennessee, United States

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Herbert D. Aronow, MD, MPH

  Medical Director, Heart & Vascular Services
  Henry Ford Health
  Detroit, Michigan, United States

  Disclosure information not submitted.
• 

  Flavio Luciano Ribichini, MD

  Chairman Heart Lung and Vascular Department
  University of Verona Hospitals
  Verona, Veneto, Italy

  Disclosure information not submitted.
• 

  Alejandro Ricalde, MD

  Director
  CITIC/ ABC MEdical Center, Distrito Federal, Mexico

  Disclosure(s): kardion: Grant/Research Support (Ongoing)
• 

  Judith Veis, MD

  Section Director, Nephrology
  Medstar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Giora Weisz, MD

  Interventional Cardiology
  NewYork Presbyterian Hospital - Columbia University Medical Center
  New York, New York, United States

  Disclosure(s): Pulnovo: Consulting Fees (e.g., advisory boards) (Ongoing)